相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PRMT1 promotes neuroblastoma cell survival through ATF5
Zhong-Yan Hua et al.
ONCOGENESIS (2020)
Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma
Megan E. Roche et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw et al.
CANCER CELL (2019)
438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
L L Siu et al.
ANNALS OF ONCOLOGY (2019)
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
Luca Montemurro et al.
CANCER RESEARCH (2019)
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Oyvind H. Hald et al.
ONCOGENE (2019)
Lin28 and let-7 regulate the timing of cessation of murine nephrogenesis
Alena V. Yermalovich et al.
NATURE COMMUNICATIONS (2019)
TOMM20 as a potential therapeutic target of colorectal cancer
Sang-Hee Park et al.
BMB REPORTS (2019)
MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
Ganna Oliynyk et al.
ISCIENCE (2019)
Single-cell analysis of progenitor cell dynamics and lineage specification in the human fetal kidney
Rajasree Menon et al.
DEVELOPMENT (2018)
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma
Shile Zhang et al.
CANCER LETTERS (2016)
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
Chia-Lang Hsu et al.
ONCOTARGET (2016)
NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells
Wataru Shoji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Jenny Wegert et al.
CANCER CELL (2015)
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
Anneleen Beckers et al.
CANCER LETTERS (2015)
LIN28: roles and regulation in development and beyond
Jennifer Tsialikas et al.
DEVELOPMENT (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Mutations in the transcriptional repressor REST predispose to Wilms tumor
Shazia S. Mahamdallie et al.
NATURE GENETICS (2015)
Multiple mechanisms of MYCN dysregulation in Wilms tumour
Richard D. Williams et al.
ONCOTARGET (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells
Ji Hyun Park et al.
MOLECULAR ONCOLOGY (2015)
Lin28 sustains early renal progenitors and induces Wilms tumor
Achia Urbach et al.
GENES & DEVELOPMENT (2014)
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
Dinesh Rakheja et al.
NATURE COMMUNICATIONS (2014)
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Giovana T. Torrezan et al.
NATURE COMMUNICATIONS (2014)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
ChIP-Seq Data Mining: Remarkable Differences in NRSF/REST Target Genes between Human ESC and ESC-Derived Neurons
Jun-ichi Satoh et al.
BIOINFORMATICS AND BIOLOGY INSIGHTS (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Characterization of 17.94, a novel anaplastic Wilms' tumor cell line
Keith W. Brown et al.
CANCER GENETICS (2012)
Clinically Relevant Subsets Identified by Gene Expression Patterns Support a Revised Ontogenic Model of Wilms Tumor: A Children's Oncology Group Study
Samantha Gadd et al.
NEOPLASIA (2012)
Molecular Profiling Reveals Frequent Gain of MYCN and Anaplasia-Specific Loss of 4q and 14q in Wilms Tumor
Richard D. Williams et al.
GENES CHROMOSOMES & CANCER (2011)
Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor
Richard D. Williams et al.
CLINICAL CANCER RESEARCH (2010)
Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group
Chiang-Ching Huang et al.
CLINICAL CANCER RESEARCH (2009)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Early and Late Mortality After Diagnosis of Wilms Tumor
Cecilia A. Cotton et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors
Stefanie Wittmann et al.
GENES CHROMOSOMES & CANCER (2008)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
Chromatin crosstalk in development and disease: lessons from REST
Lezanne Ooi et al.
NATURE REVIEWS GENETICS (2007)
Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters
B Zirn et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site
U Grieshammer et al.
DEVELOPMENTAL CELL (2004)
SLIT2 promoter methylation analysis in neuroblastoma, Wilms tumour and renal cell carcinoma
D Astuti et al.
BRITISH JOURNAL OF CANCER (2004)
Targeted disruption of the 3p12 gene, Dutt1/Robo1 predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter
J Xian et al.
CANCER RESEARCH (2004)
CTNNB1 mutations and overexpression of Wnt/β-catenin target genes in WT1-mutant Wilms' tumors
CM Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Derivation and characterization of a Wilms' tumour cell line, WiT 49
J Alami et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
Role of N-myc in the developing mouse kidney
CM Bates et al.
DEVELOPMENTAL BIOLOGY (2000)
分享论文
